Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Bicycle Therapeutics plc (NASDAQ: BCYC)
BCYC Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-47.60%
Analyst Rating:
BUY
Analyst Forecast (1yr):
188.70%
BCYC Stock Analysis
BCYC
PE Ratio:
BCYC
PEG Ratio:
Not Available
BCYC
Forward EPS Growth (12 month):
0.00%
BCYC
PS Ratio:
4.6
BCYC
PSG Ratio:
-0.1
BCYC
Forward Revenue Growth (12 month):
-44.40%
BCYC Articles
No data was found